Miraluma breast imaging helps our radiologists detect and identify cancerous cells in the breasts early on.
During this non-invasive nuclear medicine test, the patient receives a small amount of a radioactive substance by injection. Then, a Gamma camera takes detailed images of the breasts. The radiopharmaceutical tends to accumulate differently in cancerous and non-cancerous tissues.
Dense, fibrous breast tissue makes the accurate identification of tumors and abnormal structures difficult. The Miraluma test can produce striking pictures of malignant lesions, even in the midst of dense and fibrous breast tissue. Thus, it helps us detect malignancies that other tests may have missed.
In addition, the test often reduces the number of breast biopsies needed, and does not involve compressing the breasts as in a mammogram.